{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-YS Flucytosine",
        "VITEK\u00ae 2 Yeast Flucytosine"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K133952",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092454"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGZ"
    ],
    "Summary Letter Date": "August 5, 2014",
    "Summary Letter Received Date": "August 6, 2014",
    "Submission Date": "December 19, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "Flucytosine"
    ],
    "Specimen Type(s)": [
        "Isolated yeast colonies"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Broth microdilution",
        "MIC determination"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 AST-YS Flucytosine for automated quantitative antimicrobial susceptibility testing of yeast using VITEK 2 platforms",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of clinically significant yeast species, as a laboratory aid in determining in vitro susceptibility to antimicrobial agents with VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}